List of Publicly Traded Companies / Stocks - SIC Code 2836


Member Companies

This list is made from self-reported SIC codes that companies file with the SEC.

TickerCountryNameMarket Cap
NASDAQ:XLRN US Acceleron Pharma Inc. 850,225,623
NASDAQ:ACOR US Acorda Therapeutics, Inc. 894,230,500
NASDAQ:ADAP US Adaptimmune Therapeutics plc 0
NASDAQ:ADMA US ADMA Biologics Inc 54,352,232
NASDAQ:ADVM US Adverum Biotechnologies, Inc. 80,258,850
NASDAQ:AERI US Aerie Pharmaceuticals, Inc. 1,067,342,974
NASDAQ:AGEN US Agenus Inc. 308,937,771
NASDAQ:AMGN US Amgen Inc. 118,576,802,298
AMEX:APHB US Ampliphi Biosciences Corp. 0
NASDAQ:AGTC US Applied Genetic Technologies Corp 159,399,500
NASDAQ:ARIA US ARIAD Pharmaceuticals, Inc. 4,460,134,971
AMEX:AST US Asterias Biotherapeutics, Inc. 171,898,550
AMEX:AST.WS US Asterias Biotherapeutics, Inc. 0
NASDAQ:ATRA US Atara Biotherapeutics, Inc. 378,633,343
NASDAQ:LIFE US aTyr Pharma, Inc. 39,595,882
NASDAQ:AAVL US Avalanche Biotechnologies, Inc. 0
NASDAQ:AVXS US AveXis, Inc. 0
NASDAQ:AVIR US Aviragen Therapeutics, Inc. 53,316,924
NASDAQ:BCRX US BioCryst Pharmaceuticals, Inc. 455,631,250
NASDAQ:BIIB US Biogen Inc. 65,834,200,000
NASDAQ:BOTA US Biota Pharmaceuticals, Inc. 0
NASDAQ:TECH US Bio-Techne Corp 3,784,483,103
OTC:BTIM.WS US BioTime, Inc. 0
AMEX:BTX.WS US BioTime, Inc. 0
AMEX:BTX US BioTime, Inc. 263,046,300
NASDAQ:BLUE US bluebird bio, Inc. 2,253,485,000
NASDAQ:BCLI US BrainStorm Cell Therapeutics Inc. 49,879,203
NASDAQ:CASI US CASI Pharmaceuticals, Inc. 40,557,264
NASDAQ:CLDN US Celladon Corporation 1,828,743
NASDAQ:CBMG US Cellular Biomedicine Group, Inc. 150,287,209
NASDAQ:CSBR US Champions Oncology, Inc. 32,259,188
NASDAQ:CBPO US China Biologic Products, Inc. 2,890,529,501
NASDAQ:CDTX US Cidara Therapeutics, Inc. 98,707,801
NASDAQ:CHRS US Coherus BioSciences, Inc. 1,007,862,517
OTC:CELZ US Creative Medical Technology Holdings, Inc. 0
NASDAQ:CRIS US Curis, Inc. 344,188,894
OTC:CYDI US Cybrdi, Inc. 961,803
NASDAQ:CYTR US CytRx Corp. 27,217,418
NASDAQ:DMTX US Dimension Therapeutics, Inc. 38,158,416
NASDAQ:DSCO US Discovery Laboratories, Inc. 0
NASDAQ:EDIT US Editas Medicine, Inc. 0
NASDAQ:EIGR US Eiger BioPharmaceuticals, Inc. 19,480,085
OTC:ENZN US Enzon Pharmaceuticals, Inc. 15,477,000
NASDAQ:FATE US Fate Therapeutics, Inc. 77,726,999
OTC:FENCF US Fennec Pharmaceuticals, Inc. 22,087,080
OTC:GTHR US GeneThera, Inc. 493,537
NASDAQ:GNCA US Genocea Biosciences, Inc. 107,379,400
NASDAQ:GILD US Gilead Sciences, Inc. 109,375,116,084
NASDAQ:HALO US Halozyme Therapeutics, Inc. 1,443,158,560
AMEX:HEB US Hemispherx BioPharma, Inc. 193,644,460
NASDAQ:HSKA US Heska Corp. 545,334,632
NASDAQ:IDRA US Idera Pharmaceuticals, Inc. 173,788,920
OTC:IDRAW US Idera Pharmaceuticals, Inc. 0
OTC:SVFC US Intellicell Biosciences, Inc. 15,364
OTC:JLLM US Jolley Marketing, Inc. 0
NASDAQ:JUNO US Juno Therapeutics, Inc. 1,681,814,690
NASDAQ:KITE US Kite Pharma, Inc. 2,157,396,031
NASDAQ:LJPC US La Jolla Pharmaceutical Co. 342,600,374
NASDAQ:LBIO US Lion Biotechnologies, Inc. 319,752,259
NASDAQ:LPTN US Lpath, Inc. 75,403,069
NASDAQ:MATN US Mateon Therapeutics, Inc. 9,324,370
NASDAQ:MDGN US Medgenics, Inc. 149,533,724
OTC:MDGWW US Medgenics, Inc. 0
OTC:MCTC US MicroChannel Technologies Corp. 86,183
NASDAQ:MNTA US Momenta Pharmaceuticals, Inc. 946,950,000
OTC:MYMX US Mymetics Corp. 6,682,668
NASDAQ:NSTG US NanoString Technologies, Inc. 342,866,540
NASDAQ:NK US NantKwest, Inc. 443,421,576
NASDAQ:CUR US Neuralstem, Inc. 383,458,478
NASDAQ:NBIX US Neurocrine Biosciences, Inc. 3,394,204,151
NASDAQ:NVAX US Novavax, Inc. 359,279,760
OTC:OMBP US Omni Bio Pharmaceutical, Inc. 746,871
NASDAQ:ONVO US Organovo Holdings, Inc. 333,212,217
NASDAQ:OSIR US Osiris Therapeutics, Inc. 164,805,030
NASDAQ:OXGN US OXiGENE, Inc. 0
NASDAQ:PDLI US PDL BioPharma, Inc. 367,996,500
OTC:PSTIW US Pluristem Therapeutics, Inc. 2,386,440
NASDAQ:PSTI US Pluristem Therapeutics, Inc. 124,094,863
OTC:PCNT US Point of Care Nano-Technology, Inc. 3,265,521
OTC:BIEI US Premier Biomedical Inc 131,310
AMEX:PLX US Protalix BioTherapeutics, Inc. 43,664,299
NASDAQ:PRTO US Proteon Therapeutics, Inc. 31,281,834
NASDAQ:RGNX US REGENXBIO Inc. 179,332,141
NASDAQ:RGEN US Repligen Corp. 997,575,340
NASDAQ:RPRX US Repros Therapeutics, Inc. 32,802,300
NASDAQ:SGMO US Sangamo BioSciences, Inc. 286,003,700
NASDAQ:SGEN US Seattle Genetics, Inc. 7,456,500,609
NASDAQ:ONCE US Spark Therapeutics, Inc. 1,275,626,552
NASDAQ:STEM US StemCells, Inc. 122,633,443
OTC:CRXM US Taxus Cardium Pharmaceuticals Group, Inc. 2,314,789
OTC:TNGNQ US Tengion, Inc. 5,389
NASDAQ:TTNP US Titan Pharmaceuticals, Inc. 88,233,200
NASDAQ:TCON US TRACON Pharmaceuticals, Inc. 58,357,168
NASDAQ:TROVU US TrovaGene, Inc. 337,000,582
NASDAQ:TROV US TrovaGene, Inc. 63,485,196
NASDAQ:TROVW US TrovaGene, Inc. 10,580,866
NASDAQ:VBIV US VBI Vaccines, Inc. New 71,820,509
NASDAQ:VCEL US Vericel Corporation 66,528,000
NASDAQ:VICL US Vical Inc. 212,862,320
OTC:VODG US Vitro Diagnostics, Inc. 1,202,978
NASDAQ:VYGR US Voyager Therapeutics, Inc 48,492,300
NASDAQ:WINT US Windtree Therapeutics, Inc. 9,544,790
AMEX:XTNT US Xtant Medical Holdings, Inc. 5,252,180